(2020a) revealed that the differentially expressed genes between treated and untreated samples were mostly enriched in the metabolic process and cell cycle-related process, and further identified ATF4 as a novel prognostic biomarker of diabetic cardiomyopathy. Here, ATF4 is linked to diabetic cardiomyopathy.